Pediatrics Doctors in Dublin, GA Accepting Medicare

7 Pediatrics doctors found. Showing 1 - 7

Dr. Surendranath Kavuri, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 112 Rowe Street, Dublin, GA 31021 Phone: 478-272-5212    Fax: 478-272-5217

Dr. Leah Lord Helton, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 104 Fairview Park Dr, Dublin, GA 31021 Phone: 478-304-1414

Gyula Soos, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 102 Bowling Lane, Dublin, GA 31021 Phone: 478-272-0203    Fax: 478-272-0223

Carl O Bedingfield, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2406 Bellevue Rd, Bldg. 10, Dublin, GA 31021 Phone: 478-272-2623    Fax: 478-272-9984

Kannan Vaidyanathan, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 112 Rowe St, Dublin, GA 31021 Phone: 478-272-5212

Drew Moorman, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 104 Fairview Park Dr Ste 200, Dublin, GA 31021 Phone: 478-304-1414    Fax: 478-353-1353

Christopher Drew Carswell, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2406 Bellevue Rd, Bldg. 10, Dublin, GA 31021 Phone: 478-272-2623    Fax: 478-272-9984

News Archive

Antiplatelet monotherapy appears to be safer but does not reduce risk of heart attack

Long-term antiplatelet monotherapy after stenting is safe but does not reduce the risk of death or heart attack compared to standard dual antiplatelet therapy, according to late breaking results from the GLOBAL LEADERS trial presented today in a Hot Line Session at ESC Congress 2018 and published in The Lancet.

Elsevier to sponsor 2013 Library Connect Charleston Conference Award

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced it will sponsor the 2nd annual Elsevier Library Connect Charleston Conference Award for first time presenters participating in the 33rd Annual Charleston Conference: Issues in Book and Serial Acquisition, November 6-9, 2013.

MD Anderson and Xencor to develop novel antibody therapeutics to treat cancer patients

The University of Texas MD Anderson Cancer Center and Xencor, Inc. today announced a strategic research collaboration and commercialization agreement to develop novel CD3 bispecific antibody therapeutics for the potential treatment of patients with cancer.

HCV protease inhibitor telaprevir improves response, halves treatment time for hepatitis C patients

For patients with the most common form of hepatitis C, the addition of a hepatitis C-specific protease inhibitor called telaprevir to the current standard therapy can significantly improve the chances of being cured, and it does it in half the time of standard therapy alone.

Women are treated less frequently than men with statins, aspirin and beta-blockers

Women and men experience a similar prevalence of adverse drug reactions in the treatment of coronary artery disease; however, women are significantly less likely than their male counterparts to be treated with statins, aspirin, and beta-blockers according to a new study by researchers at Rush University Medical Center.

Read more Medical News

› Verified 3 days ago